Clinical Trial Update: PD-L1 Expression in Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update examining PD-L1 expression in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: NanoMab Technology (UK) Limited | Conditions: Non-Small Cell Lung Cancer | Phase 2 | Status: UNKNOWN